BWXT stock beats Q4/FY2025 revenue and EPS with a record $7.3B backlog but looks overvalued. Read more macro analysis here.

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...

Himanshu Mody, Partner & Head, DEPT® India, shares insights on its latest BFSI trends report, which identifies data, user ...

Claire Boyte-White is the lead writer for NapkinFinance.com, co-author of I Am Net Worthy, and an Investopedia contributor. Claire's expertise lies in corporate finance & accounting, mutual funds, ...

It’s associated with a lower risk of hypertension, Type 2 diabetes, heart disease, certain cancers, cognitive decline, ...